Also known as Azulfidine
Sulfasalazine (brand name Azulfidine in the U.S., Salazopyrin and Sulazine in Europe and Hong Kong) was developed in the 1950s specifically to treat rheumatoid arthritis. It was believed at the time that bacterial infections were the cause of rheumatoid arthritis. Sulfasalazine is a sulfa drug, (a derivative of mesalazine) and is formed by combining sulfapyridine and salicylate with an azo bond. It may be abbreviated SSZ.Source: Wikipedia
Estimated Total Cost: $20.02 for an average of 28 days supply
Patients are most commonly prescribed sulfasalazine to treat rheumatoid arthritis, crohn disease, ulcerative colitis, and joint pain.